Regeneron Pharmaceuticals Inc.
Tarrytown, NY
- UEI
- N3F9MH7E6HD6
- CAGE
- 544P9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA
- Website
- regeneron.com
- Founded
- 1988
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evkeeza drug | Veterans Integrated Service Network 1 | $494,095 | |
| Evkeeza | Veterans Integrated Service Network 1 | $148,229 | |
| Production of therapeutic in support of national emergency response to coronavirus 2019 (covid-19): in support of… | ACC Aberdeen Proving Ground | $5,565,000,000 | |
| Inmazeb ebola therapeutics | Office of the Assistant Secretary for Preparedness and Response | $973,560,407 | |
| - regeneron other transaction authority (OTA) award | Office of the Assistant Secretary for Preparedness and Response | $278,844,172 |
About Regeneron Pharmaceuticals Inc.
Products and Services
The government contractor in question primarily provides pharmaceuticals and drugs, as well as therapeutic production services. The products range from specific drugs like EVKEEZA to large-scale production of therapeutics for national emergencies, such as the COVID-19 pandemic. Over time, the contractor has expanded its services from supplying specific pharmaceutical products to large-scale production of therapeutics.
Customers
The contractor has been awarded contracts by various government agencies, including the Department of Veterans Affairs (VA), the Department of Defense (DOD) - specifically the Army and the USASC, and the Department of Health and Human Services (HHS). Over time, the contractor has expanded its customer base from the VA and HHS to include the DOD. The top buyers from this contractor are the DOD and HHS, given the high value of the contracts awarded by these agencies. The contractor's awards are associated with set-asides such as the Operation Warp Speed (OWS) for COVID-19 response.
Vehicles
The contract vehicles under which this contractor is awarded include BPA Call, Definitive Contract, and Delivery Order. Over time, the contractor has been awarded increasingly larger contracts, moving from Delivery Orders to Definitive Contracts and BPA Calls, indicating an expansion in the scale of the contractor's operations.
Summary
The contractor has shown a trend of expanding its services and customer base over time. It has moved from supplying specific pharmaceutical products to large-scale production of therapeutics, and from serving the VA and HHS to include the DOD. The contractor's awards are associated with significant national responses, such as the COVID-19 pandemic.
Data
The analysis is based on seven contracts awarded between 09/27/13 and 11/24/21.
Contract vehicles
Quick answers
What is Regeneron Pharmaceuticals Inc.'s UEI?
Regeneron Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is N3F9MH7E6HD6.
What is Regeneron Pharmaceuticals Inc.'s CAGE code?
Regeneron Pharmaceuticals Inc.'s CAGE code is 544P9.
What is Regeneron Pharmaceuticals Inc.'s primary NAICS code?
Regeneron Pharmaceuticals Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Regeneron Pharmaceuticals Inc. located?
Regeneron Pharmaceuticals Inc.'s physical address in SAM.gov is 777 Old Saw Mill River Rd, Tarrytown, NY 10591, USA.
Is Regeneron Pharmaceuticals Inc. registered in SAM.gov?
Yes. Regeneron Pharmaceuticals Inc.'s SAM.gov registration is active through October 16, 2026.
Which contract vehicles does Regeneron Pharmaceuticals Inc. hold?
Regeneron Pharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Regeneron Pharmaceuticals Inc.'s most recent federal award?
Regeneron Pharmaceuticals Inc.'s most recent federal contract award is Evkeeza drug (36C24122N0160), from Veterans Integrated Service Network 1, on November 24, 2021.
On GovTribe
See Regeneron Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors